Towa Pharmaceutical Balance Sheet Health
Financial Health criteria checks 3/6
Towa Pharmaceutical has a total shareholder equity of ¥148.8B and total debt of ¥196.2B, which brings its debt-to-equity ratio to 131.8%. Its total assets and total liabilities are ¥414.7B and ¥265.9B respectively. Towa Pharmaceutical's EBIT is ¥13.4B making its interest coverage ratio 17.8. It has cash and short-term investments of ¥30.7B.
Key information
131.8%
Debt to equity ratio
JP¥196.17b
Debt
Interest coverage ratio | 17.8x |
Cash | JP¥30.70b |
Equity | JP¥148.82b |
Total liabilities | JP¥265.87b |
Total assets | JP¥414.69b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 4553's short term assets (¥213.2B) exceed its short term liabilities (¥77.0B).
Long Term Liabilities: 4553's short term assets (¥213.2B) exceed its long term liabilities (¥188.9B).
Debt to Equity History and Analysis
Debt Level: 4553's net debt to equity ratio (111.2%) is considered high.
Reducing Debt: 4553's debt to equity ratio has increased from 70.1% to 131.8% over the past 5 years.
Debt Coverage: 4553's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: 4553's interest payments on its debt are well covered by EBIT (17.8x coverage).